Understanding and Treating LGBTQI+ Patients with Cancer
Chasity Burrows Walters, PhD, RN, Memorial Sloan Kettering Cancer Center, New York, NY
Chronic Myeloid Leukemia: What HCPs Need to Know
Ehab Atallah, MD, Medical College of Wisconsin, Milwaukee, WI
2022 ASH Annual Meeting: Highlights from the Perspective of a Conference Attendee
Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY
Understanding Waldenström Macroglobulinemia
Shayna Sarosiek, MD, Dana Farber Cancer Institute, Boston, MA
CAR T-cell Therapy in Review 2022: Updates in Treatment
Sattva S. Neelapu, MD, M.D. Anderson Cancer Center, Houston, TX
Shared Decision Making with Your Patients Diagnosed with a Chronic Leukemia: Part II
Daphne Friedman, MD, Durham VA Health Care System, Durham, NC
AML: Insights, Updates, and Takeaways
Eytan M. Stein, MD, Memorial Sloan Kettering Cancer Center, New York, NY
Insights from Attending the 2022 Society of Hematologic Oncology (SOHO) Annual Meeting
Saad Z. Usmani, MD, MBA, FACP, Memorial Sloan Kettering Cancer Center, New York, NY
What’s New in the Treatment of BPDCN?
Naveen Pemmaraju, MD, The University of Texas MD Anderson Cancer Center, Houston, TX
Mastocytosis: Insight into a Rare Blood Cancer
Jason Gotlib, MD, Stanford University School of Medicine, Palo Alto, CA
The Role of Genomics in Treating Blood Cancers
Rafael Fonseca, MD, Mayo Clinic, Phoenix, AZ
Insights into Pediatric Survivorship for the HCP
Kevin C. Oeffinger, MD, FASCO, Duke University Medical Center, Durham, NC
PedAL: First-of-Its-Kind Global Master Clinical Trial for Pediatric Acute Leukemia
Gwen L. Nichols, MD, The Leukemia & Lymphoma Society, Rye Brook, NY
The Role of the Primary Care Physician in Treating Chronic Blood Cancers: Focus on Myeloma
Zalman Suldan, MD, PhD, Hackensack University Medical Center – Hackensack Meridian Health, Hackensack, NJ
CAR T-cell Therapy in 2022: What You Need to Know Part II
Rayne H. Rouce, MD, BS, Texas Children’s Cancer Center for Cell and Gene Therapy, Houston, TX
Everything You Need to Know About Cutaneous T-cell Lymphoma
Francine Foss, MD and John A. Zic, MD, MMHC
A Deep Dive into Myelofibrosis
Srdan Verstovsek, MD, PhD, MD Anderson Cancer Center, Houston, TX
Shared Decision Making with Your Patients Diagnosed with a Chronic Leukemia: Part I
Jacqueline C. Barrientos, MD, MS, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY
CAR T-cell Therapy in 2022: What You Need to Know
Caron Jacobson, MD, Dana-Farber Cancer Institute, Boston, MA
Highpoints from Attending the 2021 American Society of Hematology Conference
Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY
Updates on COVID-19 in Patients with Blood Cancer
John P. Leonard, MD, Weill Cornell Medicine, New York Presbyterian, New York, NY
A Conversation on Adult Survivorship
Maria Alma Rodriguez, MD, MACP, CMQ, The University of Texas MD Anderson Cancer Center, Houston, TX
The Advanced Practice Provider’s Role in Treating Newly Diagnosed Patients with Myeloma
Daniel Verina, DNP, ACNP-BC, Mount Sinai Medical Center, New York, NY
The Physician’s Role in Treating Newly Diagnosed Patients with Myeloma
Joshua Richter, MD, Icahn School of Medicine at Mount Sinai, New York, NY
Clinical Trials: A Healthcare Professional’s Perspective
Lorenzo Falchi, MD and Leah Szumita, MS, RN, CCRN, ACNS-BC
Wearing Two Hats: Supporting the Childhood Cancer Patient as Nurse & Parent
David Tate, BSN, RN, PHN, Rio Bravo-Greeley School, Bakersfield, CA
Addressing Healthcare Disparities in Cancer Care
Justine M. Kahn, MD, MS, Columbia University Irving Medical Center, New York, NY
T-cell Lymphoma: A Discussion on Treatment and Patient Support
Steven Horwitz, MD, Memorial Sloan Kettering Cancer Center, New York, NY
A Discussion on MRD: Practical Information for Providers
Jeffrey L. Wolf, MD, University of California San Francisco, San Francisco, CA
A Deeper Dive into Cancer Genomics
Justin M. Watts, MD, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL